EUCTR2014-000967-42-NL进行中（未招募）1 期
Strengthening memory immunity in the aged population by vaccinating re-elderly - StimulAge study
ational Institute for Public Health and the Environment (RIVM)0 个研究点目标入组 250 人开始时间: 2014年5月12日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •In order to be eligible to participate in this study, participants must meet
- •all of the following criteria:
- •General good health
- •50-65 years of age
- •Provision of written informed consent;
- •Adherent to protocol and available during the study period.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 250
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Any of the following criteria will exclude a participant from this study:
- •Antibiotic use within 14 days of enrollment;
- •Present evidence of serious disease(s) demanding immunosuppressive
- •medical treatment, like corticosteroids, that might interfere with the
- •results of the study within the last 3 months;
- •Known or suspected allergy to any of the vaccine components (by
- •medical history);
- •Occurrence of serious adverse event after other vaccination (by
- •medical history);
- •Known or suspected immune deficiency;
- •Known or suspected coagulation disorder;
- •Hormone use, such as post-menopausal hormone or contraceptive
- •pills, within the last 3 months;
- •History of any neurologic disorder, including epilepsy;
- •Previous administration of serum products (including
- •immunoglobulins) within 6 months before vaccination and blood
- •Serious surgery within the last 3 months;
- •Previous vaccination with the MenC, MenC-TT, or MenACWY-TT
- •vaccine. (for the MenACWY-TT study group )
- •Previous meningococcal episode (MenACWY-TT study group)
- •Previous vaccination with VZV vaccine
- •Previous Varicella Zoster episode (VZV study group)
- •Vaccination with DT, DT-IPV, TdaP or T within the past 10 years (for
- •the MenACWY-TT study group)
- •Any vaccination within a month before enrollment;
- •Pregnancy
研究者
相似试验
已完成
4 期
Strengthening memory immunity in the aged population by vaccinating pre-elderlyvirale infectziekten (niet meer in te vullen boven)Determine differences in vaccine response in the pre-elderly age group (50-65 years of age) to the MenACWY-TT and VZV vaccine.10004018NL-OMON47511RIVM207
尚未招募
不适用
Strengthening memory immunity in the aged population by vaccinating pre-elderlyvaccin, pre-elderly, immunesenescence, ageing, biomarkersNL-OMON25211RIVM, UMCG250
终止
4 期
Enhancing Memory Consolidation in Older AdultsAgingNCT03657212University of California, Irvine10
撤回
不适用
Aging-related memory impairment: a behavior-genomics studyNo disorder: Age-related memory performance10042258NL-OMON43432Takeda220
已完成
不适用
Older People and Enhanced Neurocognitive function studyerve and cognitive functionNervous System DiseasesCognitive functionISRCTN54195799ondon School of Hygiene and Tropical Medicine (LSHTM) (UK)200